# FDA Inspection 1211630 - BASF Pharma (Callanish) Ltd. - December 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/basf-pharma-callanish-ltd/ec1e21fa-3d4c-4935-aa6e-b50b1801e218
Source feed: FDA_Inspections

> FDA Inspection 1211630 for BASF Pharma (Callanish) Ltd. on December 01, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211630
- Company Name: BASF Pharma (Callanish) Ltd.
- Inspection Date: 2022-12-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1153218 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/basf-pharma-callanish-ltd/4bf336b6-e431-40b3-a6e2-ed6eb1d5a163)
- [FDA Inspection 977686 - 2016-06-10](https://www.keypedia.com/records/fda_inspections/basf-pharma-callanish-ltd/d7526835-0b65-4951-a8d5-eb4e0622e1a7)
- [FDA Inspection 827310 - 2013-04-11](https://www.keypedia.com/records/fda_inspections/basf-pharma-callanish-ltd/16d04266-026d-4dd0-92d9-f3453bb183f3)

Company: https://www.keypedia.com/companies/basf-pharma-callanish-ltd/e5d63366-eeba-4b70-a5f6-f267dc12496f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c